Krystal Biotech (KRYS) Operating Margin Growth (1y) (2024 - 2026)

Krystal Biotech (KRYS) Operating Margin Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,552.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -170.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Krystal Biotech 9.59 Bn 8.77 Bn 110.08 Mn 501.00

Historic Data

Download Data
DateValue
Mar 31, 2026 501.00
Dec 31, 2025 -406.00
Sep 30, 2025 1,550.00
Jun 30, 2025 2,874.00
Mar 31, 2025 5,588.00
Dec 31, 2024 3,769.00
Sep 30, 2024 33,060.00